Goodwill of Pacira BioSciences, Inc. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Pacira BioSciences, Inc. quarterly Goodwill in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • Pacira BioSciences, Inc. Goodwill for the quarter ending 31 Dec 2025 was $20,214,000.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Pacira BioSciences, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $20,214,000 +$20,214,000 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $20,317,000 +$20,317,000 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $20,300,000 -$142,943,000 -88% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $21,520,000 -$141,723,000 -87% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $0 -$163,243,000 -100% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $0 -$163,243,000 -100% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $163,243,000 $0 0% 30 Jun 2024 10-Q 30 Jul 2024 2024 Q2
Q1 2024 $163,243,000 $0 0% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $163,243,000 $0 0% 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $163,243,000 +$5,882,000 +3.7% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $163,243,000 +$17,111,000 +12% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $163,243,000 +$17,521,000 +12% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $163,243,000 +$18,043,000 +12% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $157,361,000 +$57,814,000 +58% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $146,132,000 +$46,585,000 +47% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $145,722,000 +$46,175,000 +46% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $145,200,000 +$45,653,000 +46% 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $99,547,000 $0 0% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $99,547,000 $0 0% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $99,547,000 $0 0% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $99,547,000 $0 0% 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $99,547,000 $0 0% 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $99,547,000 -$991,000 -0.99% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $99,547,000 +$37,507,000 +60% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $99,547,000 +$37,507,000 +60% 31 Dec 2019 10-K 28 Feb 2022 2021 FY
Q3 2019 $99,547,000 +$37,507,000 +60% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $100,538,000 +$40,626,000 +68% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $62,040,000 +$4,550,000 +7.9% 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 $62,040,000 +$6,843,000 +12% 31 Dec 2018 10-K 01 Mar 2021 2020 FY
Q3 2018 $62,040,000 +$9,084,000 +17% 30 Sep 2018 10-Q 01 Nov 2018 2018 Q3
Q2 2018 $59,912,000 +$8,969,000 +18% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 $57,490,000 +$8,661,000 +18% 31 Mar 2018 10-Q 03 May 2018 2018 Q1
Q4 2017 $55,197,000 +$8,460,000 +18% 31 Dec 2017 10-K 21 Feb 2020 2019 FY
Q3 2017 $52,956,000 +$8,286,000 +19% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 $50,943,000 +$8,192,000 +19% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 $48,829,000 +$16,045,000 +49% 31 Mar 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 $46,737,000 +$15,857,000 +51% 31 Dec 2016 10-K 28 Feb 2019 2018 FY
Q3 2016 $44,670,000 +$15,782,000 +55% 30 Sep 2016 10-Q 02 Nov 2016 2016 Q3
Q2 2016 $42,751,000 +$15,628,000 +58% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 $32,784,000 +$7,403,000 +29% 31 Mar 2016 10-Q 02 May 2016 2016 Q1
Q4 2015 $30,880,000 +$7,119,000 +30% 31 Dec 2015 10-K 28 Feb 2018 2017 FY
Q3 2015 $28,888,000 +$6,840,000 +31% 30 Sep 2015 10-Q 27 Oct 2015 2015 Q3
Q2 2015 $27,123,000 +$14,603,000 +117% 30 Jun 2015 10-Q 30 Jul 2015 2015 Q2
Q1 2015 $25,381,000 +$14,054,000 +124% 31 Mar 2015 10-Q 30 Apr 2015 2015 Q1
Q4 2014 $23,761,000 +$13,433,000 +130% 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q3 2014 $22,048,000 +$12,509,000 +131% 30 Sep 2014 10-Q 30 Oct 2014 2014 Q3
Q2 2014 $12,520,000 +$3,540,000 +39% 30 Jun 2014 10-Q 31 Jul 2014 2014 Q2
Q1 2014 $11,327,000 +$2,745,000 +32% 31 Mar 2014 10-Q 01 May 2014 2014 Q1
Q4 2013 $10,328,000 +$2,031,000 +24% 31 Dec 2013 10-K 25 Feb 2016 2015 FY
Q3 2013 $9,539,000 +$1,430,000 +18% 30 Sep 2013 10-Q 31 Oct 2013 2013 Q3
Q2 2013 $8,980,000 +$988,000 +12% 30 Jun 2013 10-Q 06 Aug 2013 2013 Q2
Q1 2013 $8,582,000 +$582,000 +7.3% 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 $8,297,000 +$8,297,000 31 Dec 2012 10-K 24 Feb 2015 2014 FY
Q3 2012 $8,109,000 30 Sep 2012 10-Q 01 Nov 2012 2012 Q3
Q2 2012 $7,992,000 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 $8,000,000 30 Apr 2012 10-Q 02 Aug 2018 2018 Q2
Q4 2011 $0 31 Dec 2011 10-K 25 Feb 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.